To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
1. Broad-spectrum antibiotics should be ordered and administered within 60 minutes of patient arrival to the ED.
2. If possible, obtain blood cultures prior to starting antibiotics. However, the administration of antibiotics should not be delayed for the collection of blood cultures.
3. If a patient is known to have a history of multidrug resistant organisms, antibiotic choice will need to be adjusted according to history, if known, or consider consulting Infectious Disease for assistance.
4. Patients with neutropenic fever can deteriorate into sepsis rapidly and therefore, need to be monitored closely.
5. For patients with elevated lactic acid/lactate, it is important to repeat this lab value following a fluid bolus to monitor for clinical deterioration and the development of sepsis.
1. Patients with neutropenic fever who are found to be low risk based on clinical judgment and MASCC or CISNE score, can be discharged home with oral antibiotics and close follow up. Those who are found to be high risk, should be admitted for IV antibiotics.
2. Patients who are taking an oral fluoroquinolone for prophylactic therapy are not candidates for fluoroquinolone therapy for treatment of neutropenic fever and should be admitted to the hospital for IV antibiotics.
3. Patients who use a feeding tube as their primary route for nutrition and medication are not appropriate for outpatient neutropenic fever treatment.
4. If a patient is monitored in the ED and continues to be febrile despite administration of antibiotics, the patient may need to be admitted for IV antibiotics versus being discharged home on oral antibiotics.
5. If a patient is known to have a history of multidrug resistant organisms consider consulting Infectious Disease for assistance in antibiotic selection.
Joshua Lowe, San Antonio Military Medical Center,Rachel Bridwell, Uniformed Services University of Health Sciences,John Patrick, San Antonio Military Medical Center,Alec Pawlukiewicz, Carl R. Darnall Army Medical Center,Gillian Schmitz, Uniformed Services University of Health Sciences,Michael Yoo, University of Texas Health San Antonio
This case explores the evaluation and management of neutropenic fever in a 22-year-old female with lupus nephritis who recently received cyclophosphamide. The patient presents with nonspecific symptoms (fever, chills, and fatigue) but no focal signs of infection. Her profound neutropenia (ANC < 0.1) confirms a diagnosis of chemotherapy-induced neutropenic fever. In such immunocompromised patients, infections can progress rapidly without classic signs, necessitating urgent empiric antibiotic coverage. Learners will gain exposure to the diagnostic and therapeutic approach to neutropenic fever, including risk stratification, culture collection, and empiric treatment initiation. The case also highlights the importance of interdisciplinary collaboration with hematology and rheumatology to guide ongoing care and immunosuppressive management.
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
Overview of toxicities related to immunotherapy agents, and other complications in the lymphatic system such as tumor lysis, hyperviscosity syndrome, graft vs host disease, and neutropenic fever
This chapter discusses the diagnosis, evaluation and management of neutropenic fever. The initial presentation of the critically ill with neutropenic fever may be overt with a clinical presentation similar to that of septic shock and including hypotension, respiratory failure, or any other major organ dysfunction. It may also be cryptogenic with isolated confusion, coagulopathy, or cardiac arrhythmias. Elderly patients and those taking steroids may present as hypothermic or euthermic. Any unexplained acute clinical deterioration should be considered a fever equivalent. Critically ill patients with neutropenic fever will most frequently present with common infections. However, their immunocompromised state places them at risk for more complex disease processes of almost any organ system. The pathophysiology of the decompensating patient with neutropenic fever is similar to that of a patient in septic shock. Those patients should be resuscitated similarly by the rapid and aggressive administration of crystalloids.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.